Diffusion-weighted Magnetic Resonance Imaging for Predicting and Detecting Early Response to Chemoradiation Therapy of Squamous Cell Carcinomas of the Head and Neck

Overview

Journal Clin Cancer Res

Specialty Oncology

Date 2009 Feb 4

PMID 19188170

Citations 182

Authors

Sungheon Kim

Laurie Loevner

Harry Quon

Eric Sherman

Gregory Weinstein

Alex Kilger

Harish Poptani

Affiliations

Soon will be listed here.

Abstract

Purpose: The aim of this study was to investigate the utility of apparent diffusion coefficient (ADC) for prediction and early detection of treatment response in head and neck squamous cell carcinomas (HNSCC).

Experimental Design: Diffusion-weighted magnetic resonance imaging studies were performed on 40 patients with newly diagnosed HNSCC before, during, and after the end of chemoradiation therapy. Analysis was done on data from 33 patients after exclusion of 7 patients that had incomplete data.

Results: Pretreatment ADC value of complete responders (1.04 +/- 0.19 x 10(-3) mm2/s) was significantly lower (P < 0.05) than that from partial responders (1.35 +/- 0.30 x 10(-3) mm2/s). A significant increase in ADC was observed in complete responders within 1 week of treatment (P < 0.01), which remained high until the end of the treatment. The complete responders also showed significantly higher increase in ADC than the partial responders by the first week of chemoradiation (P < 0.01). When pretreatment ADC value was used for predicting treatment response, the area under the receiver operating characteristic curve was 0.80 with a sensitivity of 65% and a specificity of 86%. However, change in ADC within the first week of chemoradiation therapy resulted in an area under the receiver operating characteristic curve of 0.88 with 86% sensitivity and 83% specificity for prediction of treatment response.

Conclusions: These results suggest that ADC can be used as a marker for prediction and early detection of response to concurrent chemoradiation therapy in HNSCC.

Citing Articles

Interpretable survival network for progression risk analysis of multimodality imaging biomarkers in poor-prognosis head and neck cancers.

Wei L, Aryal M, Lee C, Shah J, Mierzwa M, Cao Y Sci Rep. 2024; 14(1):30004.

PMID: 39622922 PMC: 11612283. DOI: 10.1038/s41598-024-80815-2.

The apparent diffusion coefficient can serve as a predictor of survival in patients with gliomas.

Jiang X, Xu X, Yuan X, Jiang H, Zhao M, Duan Y Radiat Oncol. 2024; 19(1):149.

PMID: 39472956 PMC: 11524024. DOI: 10.1186/s13014-024-02535-1.

Predictive markers for head and neck cancer treatment response: T1rho imaging in nasopharyngeal carcinoma.

Ai Q, King A, Tsang Y, Yu Z, Mao K, Mo F Eur Radiol. 2024; 35(3):1265-1275.

PMID: 39191996 PMC: 11836102. DOI: 10.1007/s00330-024-10948-5.

Diffusion-weighted magnetic resonance imaging as an early prognostic marker of chemoradiotherapy response in squamous cell carcinoma of the anus: An individual patient data -analysis.

Hanekamp B, Virdee P, Goh V, Jones M, Hansen R, Johannesen H Phys Imaging Radiat Oncol. 2024; 31:100618.

PMID: 39188809 PMC: 11345337. DOI: 10.1016/j.phro.2024.100618.

Dataset of weekly intra-treatment diffusion weighted imaging in head and neck cancer patients treated with MR-Linac.

El-Habashy D, Wahid K, He R, McDonald B, Mulder S, Ding Y Sci Data. 2024; 11(1):487.

PMID: 38734679 PMC: 11088675. DOI: 10.1038/s41597-024-03217-z.

References

McVeigh P, Syed A, Milosevic M, Fyles A, Haider M . Diffusion-weighted MRI in cervical cancer. Eur Radiol. 2008; 18(5):1058-64. DOI: 10.1007/s00330-007-0843-3. View

Obuchowski N . Receiver operating characteristic curves and their use in radiology. Radiology. 2003; 229(1):3-8. DOI: 10.1148/radiol.2291010898. View

Raatschen H, Simon G, Fu Y, Sennino B, Shames D, Wendland M . Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats. Radiology. 2008; 247(2):391-9. PMC: 4423757. DOI: 10.1148/radiol.2472070363. View

Mukherji S, Schiro S, Castillo M, Kwock L, Muller K, Blackstock W . Proton MR spectroscopy of squamous cell carcinoma of the extracranial head and neck: in vitro and in vivo studies. AJNR Am J Neuroradiol. 1997; 18(6):1057-72. PMC: 8337295. View

Hayano K, Okazumi S, Shuto K, Matsubara H, Shimada H, Nabeya Y . Perfusion CT can predict the response to chemoradiation therapy and survival in esophageal squamous cell carcinoma: initial clinical results. Oncol Rep. 2007; 18(4):901-8. View

Ang K, Harris J, Garden A, Trotti A, Jones C, Carrascosa L . Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: radiation therapy oncology group phase II trial 99-14. J Clin Oncol. 2005; 23(13):3008-15. DOI: 10.1200/JCO.2005.12.060. View

Shukla-Dave A, Poptani H, Loevner L, Mancuso A, Serrai H, Rosenthal D . Prediction of treatment response of head and neck cancers with P-31 MR spectroscopy from pretreatment relative phosphomonoester levels. Acad Radiol. 2002; 9(6):688-94. DOI: 10.1016/s1076-6332(03)80314-8. View

Gupta R, Cloughesy T, Sinha U, Garakian J, Lazareff J, Rubino G . Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J Neurooncol. 2001; 50(3):215-26. DOI: 10.1023/a:1006431120031. View

Poptani H, Puumalainen A, Grohn O, Loimas S, KAINULAINEN R, Yla-Herttuala S . Monitoring thymidine kinase and ganciclovir-induced changes in rat malignant glioma in vivo by nuclear magnetic resonance imaging. Cancer Gene Ther. 1998; 5(2):101-9. View

10.

Chenevert T, McKeever P, Ross B . Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res. 1998; 3(9):1457-66. View

11.

Wang J, Takashima S, Takayama F, Kawakami S, Saito A, Matsushita T . Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology. 2001; 220(3):621-30. DOI: 10.1148/radiol.2202010063. View

12.

El-Deiry M, Funk G, Nalwa S, Karnell L, Smith R, Buatti J . Long-term quality of life for surgical and nonsurgical treatment of head and neck cancer. Arch Otolaryngol Head Neck Surg. 2005; 131(10):879-85. DOI: 10.1001/archotol.131.10.879. View

13.

Maes F, Collignon A, Vandermeulen D, Marchal G, Suetens P . Multimodality image registration by maximization of mutual information. IEEE Trans Med Imaging. 1997; 16(2):187-98. DOI: 10.1109/42.563664. View

14.

Thukral A, Thomasson D, Chow C, Eulate R, Wedam S, Gupta S . Inflammatory breast cancer: dynamic contrast-enhanced MR in patients receiving bevacizumab--initial experience. Radiology. 2007; 244(3):727-35. DOI: 10.1148/radiol.2443060926. View

15.

Abdel Razek A, Kandeel A, Soliman N, El-shenshawy H, Kamel Y, Nada N . Role of diffusion-weighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. AJNR Am J Neuroradiol. 2007; 28(6):1146-52. PMC: 8134145. DOI: 10.3174/ajnr.A0491. View

16.

Zorat P, Paccagnella A, Cavaniglia G, Loreggian L, Gava A, Mione C . Randomized phase III trial of neoadjuvant chemotherapy in head and neck cancer: 10-year follow-up. J Natl Cancer Inst. 2004; 96(22):1714-7. DOI: 10.1093/jnci/djh306. View

17.

Zima A, Carlos R, Gandhi D, Case I, Teknos T, Mukherji S . Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy?. AJNR Am J Neuroradiol. 2007; 28(2):328-34. PMC: 7977386. View

18.

Zonari P, Baraldi P, Crisi G . Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging. Neuroradiology. 2007; 49(10):795-803. DOI: 10.1007/s00234-007-0253-x. View

19.

Maeda M, Kato H, Sakuma H, Maier S, Takeda K . Usefulness of the apparent diffusion coefficient in line scan diffusion-weighted imaging for distinguishing between squamous cell carcinomas and malignant lymphomas of the head and neck. AJNR Am J Neuroradiol. 2005; 26(5):1186-92. PMC: 8158607. View

20.

Tzika A . Proton magnetic resonance spectroscopic imaging as a cancer biomarker for pediatric brain tumors (Review). Int J Oncol. 2008; 32(3):517-26. DOI: 10.3892/ijo_32_3_517. View